A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas.

A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas.
复制标题

DOI：
10.1016/j.radonc.2005.04.005
复制
发表时间：
2005-07
期刊：
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
影响因子：
--
通讯作者：
K. Tedesco;J. Berlin;M. Rothenberg;H. Choy;K. Wyman;Adrian Scott Pearson;R. Daniel Beauchamp;N. Merchant;A. Lockhart;Y. Shyr;Carol Caillouette;B. Chakravarthy
K. Tedesco;J. Berlin;M. Rothenberg;H. Choy;K. Wyman;Adrian Scott Pearson;R. Daniel Beauchamp;N. Merchant;A. Lockhart;Y. Shyr;Carol Caillouette;B. Chakravarthy
中科院分区：
其他
文献类型：
--
作者：
K. Tedesco;J. Berlin;M. Rothenberg;H. Choy;K. Wyman;Adrian Scott Pearson;R. Daniel Beauchamp;N. Merchant;A. Lockhart;Y. Shyr;Carol Caillouette;B. Chakravarthy

文献摘要

相似文献